Reviva Pharmaceuticals Holdings, Inc. , a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases.
Reviva Pharmaceuticals Holdings stock last closed at $1.87, down 19.4% from the previous day, and has decreased 91.34% in one year. It has underperformed other stocks in the Biotechnology industry by 0.53 percentage points. Reviva Pharmaceuticals Holdings stock is currently +2.75% from its 52-week low of $1.82, and -92.01% from its 52-week high of $23.40.
There are currently 5.75M RVPH shares outstanding. The market value of RVPH is $10.76M. In the last 24 hours, 992,000 RVPH shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy RVPH stock.
Based on our research, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, you need to fill out some personal info so you are able to invest in RVPH stock today.
Now that you've created your account on the best investment app, you need to deposit funds:
Check out the walkthrough below if you need help depositing funds into your investment account.
Once you have selected the best place to buy Reviva Pharmaceuticals Holdings stock, it's important to evaluate their stock prior to buying, so you can understand the risk and upside.
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis.
You can view all of the due diligence checks on RVPH's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge RVPH's true value.
Using relative valuations methods:
You can access additional valuation analysis on RVPH's stock here.
Out of 4 Wall Street analysts who track RVPH, the consensus analyst rating on RVPH is a Strong Buy
It's important to note that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Reviva Pharmaceuticals Holdings stock forecast page.
Over the past 12 months, insiders at RVPH have not bought or sold any shares.
Learn more about who owns RVPH stock here.
No, Reviva Pharmaceuticals Holdings doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary types of orders:
Hit the Open Trade button and your broker will place your order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
Now that you own some RVPH shares, you'll want to keep up with your investment.
Add RVPH to a watchlist to track the most important metrics related to your RVPH stock.
To reiterate, here are the 6 steps you need to take to buy Reviva Pharmaceuticals Holdings stock right now:
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Reviva Pharmaceuticals Holdings, add RVPH to your watchlist by clicking the button below.